Brief: PYC Therapeutics Says US FDA Grants Orphan Drug Designation To PYC Drug Candidate
24/05/2024 24:53
May 24 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* US FDA GRANTS ORPHAN DRUG DESIGNATION TO PYC DRUG
CANDIDATE
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director